Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

被引：10
|
作者：
Nielsen, Torsten O.
Cheang, Maggie C. U.
Chia, Stephen K.
Voduc, David
Gao, Dongxia
Leung, Samuel
Bernard, Philip S.
Perou, Charles M.
Ellis, Matthew J.
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 24期
关键词：
ESTROGEN-RECEPTOR;
D O I：
10.1093/jnci/djp390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1730 / 1730
页数：1
相关论文
共 50 条
  • [21] Luminal (Her2 negative) prognostic index and survival of breast cancer patients
    Chen, Xuesong
    Cong, Yingying
    Pan, Lihua
    Jiang, Ying
    Meng, Qingwei
    Sun, Lichun
    Pang, Hui
    Zhao, Yanbin
    Dong, Xiaoqun
    Cai, Li
    CANCER EPIDEMIOLOGY, 2014, 38 (03) : 286 - 290
  • [22] Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients
    Jaskulski, Stefanie
    Jung, Audrey Y.
    Rudolph, Anja
    Johnson, Theron
    Thoene, Kathrin
    Herpel, Esther
    Sinn, Peter
    Chang-Claude, Jenny
    MOLECULAR NUTRITION & FOOD RESEARCH, 2017, 61 (11)
  • [23] Accuracy of estrogen receptor, progesterone receptor, HER2 Status and Ki67 labeling index between core needle and surgical excisional tumour in 910 patients with breast cancer
    Nakamura, Rikiya
    Yamamoto, Naohito
    Itookubo, Yoshiyuki
    Nakagawa, Ayako
    Itami, Makiko
    CANCER RESEARCH, 2015, 75
  • [24] A prognostic index employing ki67, tumor size and lymph nodal status in luminal breast cancer patients undergoing breast conservation and adjuvant radiotherapy
    Franco, P.
    Osella-Abate, S.
    Vella, A.
    Arcadipane, F.
    Cassoni, P.
    Ricardi, U.
    Castellano, I.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S63 - S63
  • [25] Ki67 in Breast Cancer:The Effect of Different Length of Fixation on Ki 67 Index
    Faragalla, H. F.
    Feeley, L.
    Bane, A.
    Mulligan, A. M.
    MODERN PATHOLOGY, 2013, 26 : 40A - 40A
  • [26] RE: Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group
    Zhang, Jiandi
    Yang, Maozhou
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (11): : 1595 - 1596
  • [27] Ki67 in young patients with breast cancer
    Vasseur, F.
    Baranzelli, M. -C.
    Fournier, C.
    Bonneterre, J.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (01): : 16 - 19
  • [28] Reliability of preoperative core needle biopsy for determing ER, PR, HER2 status and Ki67 expression in invasive breast cancer
    Lakic, T.
    Ivkovic-Kapicl, T.
    Lovrenski, A.
    Sabo, J. Ilic
    Vuckovic-Hardi, L.
    Jelicic, I.
    VIRCHOWS ARCHIV, 2015, 467 : S52 - S52
  • [29] Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer
    Claudette Falato
    Julie Lorent
    Edneia Tani
    Eva Karlsson
    Paul K. Wright
    Jonas Bergh
    Theodoros Foukakis
    Breast Cancer Research and Treatment, 2014, 147 : 407 - 414
  • [30] Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
    Horimoto, Yoshiya
    Arakawa, Atsushi
    Tanabe, Masahiko
    Sonoue, Hiroshi
    Igari, Fumie
    Senuma, Koji
    Tokuda, Emi
    Shimizu, Hideo
    Kosaka, Taijiro
    Saito, Mitsue
    BMC CANCER, 2014, 14 : 550
12345